Raised S.B. No. 138
Session Year 2020
 


AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.

Introduced by:
General Law Committee

 New today  2-4 days old  5 days & older
   Text of Bill
 Raised Bill [doc]
  Add Notes via cookie to SB-138

Add Notes to SB-138

*NOTE: Add to My Bills and Add Notes are cookie-based functions. If device cookies are cleaned, this information will be lost.

*NOTE: Add to My Bills and Add Notes are cookie-based functions. Browser must accept cookies from cga.ct.gov to function. If browser cookies are cleaned, bills will be lost.

Co-sponsors for Amendment LCO:

Bill History

 Date Action Taken
 3/11/2020(LCO)Filed with Legislative Commissioners' Office
 3/10/2020(GL)Joint Favorable
 2/21/2020Public Hearing 02/27
 2/19/2020Referred to Joint Committee on General Law

Co-sponsors of SB-138

NOTE: Please direct all inquiries regarding the status of bills to the Office of the House Clerk and/or Senate Clerks' Office.